A Study of Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery in Patients With Melanoma Brain Metastases
Clinical trial NCT05669352 · SUSPENDED
Trial details
- NCT number
- NCT05669352
- Sponsor
- University of Florida
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2026-08-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.